Carmen García Mur, a radiologist at the Servet Hospital, recognized as one of the best doctors in Spain in 2026
September 28, 2026
Cadiz welcomes 300 participants this Thursday to the largest meeting of health research managers in the country
October 1, 2026
The conference, which will be held on October 6 at CIBA, will analyze innovation management, molecular diagnostics, and new therapeutic strategies to advance towards precision medicine.
The Aragon Health Research Institute (IIS Aragon) will hold the next October 6 the day “Innovation in the approach to lung cancer”, a meeting aimed at professionals in the biomedical, health and management fields to review some of the most relevant advances in the diagnosis, treatment and care organization of this disease.
The session will take place at the Assembly Hall of the CIBA Building in Zaragoza, at 13 San Juan Bosco Avenue, and will focus on the integration of molecular diagnostics, therapeutic innovation, clinical experience, and healthcare management as key elements for moving towards precision medicine.
The day will begin with a welcome coffee from 16 to 00 pmThe institutional opening will then take place, with the participation of Daniel Orós López, Scientific Director of the IIS Aragón, and Ramón Boria Avellanas, Director General of Inspection and Health Policy.
Innovation management, the first focus of the day
The first table will be dedicated to the innovation management in lung cancer and will be moderated by Diego Rodríguez Mena, medical director of the Lozano Blesa University Clinical Hospital of Zaragoza.
They will participate Salvador Transit, head of the Pharmacy Service of the Lozano Blesa University Clinical Hospital; José Manuel Real Campaña, Deputy Medical Director of Process Management, Quality, Safety and Training at the Miguel Servet University Hospital; and Miriam Merchante Andreu, attached to the Pharmacy Service of the Lozano Blesa University Clinical Hospital, in the Oncohematology area. The session will conclude with a discussion and conclusions.
Molecular diagnostics and new therapeutic strategies
The second table, under the title “Integrating evidence, experience and innovation in CPNM EGFR+”, will be moderated by the Dr. Lola Isla, Head of the Medical Oncology Service at the Lozano Blesa University Clinical Hospital in Zaragoza.
The session will include a presentation by Dr. Esther Conde, from the Pathological Anatomy Department of the 12 de Octubre Hospital in Madridwhich will address the impact of molecular diagnostics on precision medicine; the Dr. Joaquín Gimeno, from Medical Oncology at the Miguel Servet University Hospitalwhich will address new therapeutic strategies in EGFRm; and the Dr. Estefanía Arévalo, from Medical Oncology at the Lozano Blesa University Clinical HospitalThe panel will analyze the transition from clinical trials to daily clinical practice. The session will conclude with a discussion.
The meeting will conclude at 18:30h with the closing ceremony. The event is organized by the IIS Aragon and is sponsored by Johnson & Johnson Innovative Medicine Spain.
Participation requires prior registration through the form provided by the organization:
https://forms.gle/FMKpAuDW2ZN4BdgQ6
